1,2-Dichloroethane → HCID 178441008, compound
Reaction equation
[C:1]([CH:5]1[CH2:10][CH2:9][CH:8]([N:11]([CH2:24][C:25]2[CH:33]=[CH:32][C:28]([C:29]([OH:31])=O)=[CH:27][CH:26]=2)[C:12]2[N:16]([CH2:17][CH2:18][OH:19])[C:15]3[CH:20]=[CH:21][CH:22]=[CH:23][C:14]=3[N:13]=2)[CH2:7][CH2:6]1)([CH3:4])([CH3:3])[CH3:2].O.[NH:35]1[C:39]([NH2:40])=[N:38][N:37]=[N:36]1.C1C=CC2N(O)N=NC=2C=1.C(Cl)CCl.CCN(C(C)C)C(C)C>CN(C=O)C>[C:1]([CH:5]1[CH2:6][CH2:7][CH:8]([N:11]([CH2:24][C:25]2[CH:26]=[CH:27][C:28]([C:29]([NH:40][C:39]3[NH:38][N:37]=[N:36][N:35]=3)=[O:31])=[CH:32][CH:33]=2)[C:12]2[N:16]([CH2:17][CH2:18][OH:19])[C:15]3[CH:20]=[CH:21][CH:22]=[CH:23][C:14]=3[N:13]=2)[CH2:9][CH2:10]1)([CH3:3])([CH3:4])[CH3:2]Participants
7
Procedure
To a solution of the title compound of Example 10 Step B (0.04 mmol, 19 mg) 1H-tetraazol-5-amine monohydrate (0.13 mmol, 13 mg), HOBt (0.085 mmol, 13 mg) and EDC (0.17 mmol, 33 mg) in 0.5 mL of DMF was added DIEA (0.21 mmol, 36 μL). The reaction mixture was allowed to stand at ambient temperature overnight, then concentrated under reduced pressure. The residue was taken up in ca. 2:1 dioxane/H2O and acidified with TFA, then purified by reverse-phase chromatography (Condition B). The product was lyophilized, affording the title compound as a white solid. MS (ESI): m/z 517 (M+H). HPLC A: 1.81 min.
Workup
- concentrationconcentrated under reduced pressure
- custompurified by reverse-phase chromatography (Condition B)
Sources & evidence
- ORD record
- ord-131c5d630577494eb04e6d088c9a28db
- Source dataset
- uspto-grants-2009_07
- Patent number
- US07563815B2
Reaction notes
Loading…